AgroSavfe Corporate

Management team

Luc Maertens CEO

Luc Maertens has nearly 20 years of experience in strategy development and implementation in the Agro-industry. He has managed operations, resources and competences from research phase, over development and regulatory approval, to market entry.

Prior to joining AgroSavfe in 2017, he was Head of Syngenta’s Ghent Innovation Centre, and leading the RNA-based Biocontrol R&D Platform in Syngenta. Before that, he held a number of Science, Regulatory Affairs and operational positions in Crop Protection, Seeds and Biotechnology at Devgen NV, for Europe, Africa and Asia, and was part of the Devgen management.

He started his career in the laboratory of the VIB Department for Medical Protein Research of the Faculty of Medicine at the University of Ghent.

Mike Stepan Business Development

Mike Stepan, obtained a BSc in Agricultural Sciences in University of Nottingham, UK and has worked since then as a business manager in Animal Health, Vector Control and Crop Protection.

In January 2001 he moved to Syngenta where he had marketing responsibility for a portfolio of 35 actives across Insecticides, Herbicides and Fungicides with sales of over $4.5b and commercially directed $550m investment by Syngenta in new supply capacity.

Finally, he became head of Insecticides in 2011 (till Sept. 2017). Insecticides grew 40% to over $2b to capture No.1 leadership position in the Industry.

In February, 2018, he joined Agrosavfe to lead the Business Development.

Hilde Revets CSO

Hilde obtained her PhD in Biological Sciences in 1993 at the University of Brussels (VUB). As part of the Department of Molecular and Cellular Immunology she joined the Flanders Institute for Biotechnology (VIB) in 1997 as Principal Investigator with focus on immunology and translational research in vaccine development and antibody-based technologies, incl. biomedical applications of camelid-derived single domain antibodies.

She joined Ablynx in 2006, a Belgian biopharmaceutical company engaged in the development of Nanobodies, therapeutic proteins based on single-domain antibody fragments, holding several senior positions, translating drug development projects from discovery up to Phase II clinical trials. She also played a key role in landmark deals for Ablynx. Ablynx was acquired by Sanofi in 2018.

Till August 2018, Hilde has been managing the Vaccine & Infectious Disease Institute (VAXINFECTIO) at the University of Antwerp aiming to integrate vaccine and microbiological research. She is inventor on more than 20 patent applications and brings over 20 years of research and development experience in drug discovery & development, including antibody fragment discovery and early development, as well as technology development.

Marnix Peferoen CTO

Marnix Peferoen started his professional career with Plant Genetic Systems in 1987 and managed research programs on different traits for applications in corn, cotton and rice.

After the acquisition of Plant Genetic Systems in 1996 he was responsible for various research programs at a global level within AgrEvo, Aventis CropScience and Bayer CropScience.

Late 2005, he left Bayer CropScience and joined CropDesign to initiate the commercial development of the CropDesign trait portfolio in rice. After the acquisition of CropDesign by BASF Plant Science he was appointed as global project manager for rice.

By end 2011, he left CropDesign/BASF Plant Science and worked with VIB to establish AgroSavfe. AgroSavfe was established in 2013 with Marnix as CEO and since end March 2017, he has assumed the CTO function.

Patrick Stanssens Head Manufacturing

Patrick has more than 30 years industrial experience in biotech, having occupied various managerial R&D positions in different pharmaceutical and agricultural biotech companies. Combining a wide range of technical experience with a large practical knowledge of various legal, IP, and business matters and processes.

Prior to joining AgroSavfe in 2017, he was Head of CMC/Pharmaceutical Development at Ablynx (now Sanofi), responsible for the manufacturing of all pre-clinical and clinical trials material and overviewing strain engineering, upstream and downstream process development as well as analytics and formulation.

He obtained a MSc in Chemistry at KU Leuven, Belgium and a PhD from the laboratory of Molecular Biology, University of Ghent, Belgium.

Inge Van Daele Development Manager

Inge Van Daele started her professional career at ILVO-Plant and obtained her PhD degree in Applied Biological Sciences in 2005.

After a postdoc at the Department of Plant Systems Biology on a project in collaboration with ILVO-plant, she started working in 2010 on the AgroSavfe project at The University of Brussels and VIB. She focused on the development and testing of AGROBODY™ Bioactive-based formulations to improve retention and targeted delivery. She managed the in-house plant assays and outsourced trials.

In 2013 she joined the established company and now acts as Development Manager.

Dominique Vercammen IP Manager

Dominique Vercammen obtained his PhD degree in Biotechnology in 1998 at the former Laboratory of Molecular Biology of Prof. Dr. Walter Fiers at Gent University, now known as the Center for Inflammation Research of Gent University and VIB.

In 2001 he joined the Department of Plant Systems Biology, led by Prof. Dr. Dirk Inzé, as a post-doc fellow, studying plant cell death.

He made a shift in his career when he joined Bayer BioScience in Gent as Junior Patent Professional in 2008.

In 2009, he started as Patent Counsel at Innogenetics in Gent.

After the acquisition of Innogenetics by Fujirebio, he left the company in 2012 to start as Senior Patent Agent at Devgen in Gent, now Syngenta’s Gent Innovation Centre.

Dominique is a European Patent Attorney since 2014. He joined AgroSavfe in October 2015 as IP Manager.

Board of Directors

Lieven De Smedt

Chairman, independent, representing InnoTune BVBA

Luc Basstanie

representing Agri Investment Fund, CVBA

Adrian Percy

representing Nomad Technology Consulting LLC

Denis Lucquin

representing Sofinnova Partners

Luc Maertens

CEO and Managing Director

Koen Quaghebeur

representing K&E, BVBA

Patrick Van Beneden

representing Gimv, NV